RU2014153672A - Новые каберголиновые производные - Google Patents
Новые каберголиновые производные Download PDFInfo
- Publication number
- RU2014153672A RU2014153672A RU2014153672A RU2014153672A RU2014153672A RU 2014153672 A RU2014153672 A RU 2014153672A RU 2014153672 A RU2014153672 A RU 2014153672A RU 2014153672 A RU2014153672 A RU 2014153672A RU 2014153672 A RU2014153672 A RU 2014153672A
- Authority
- RU
- Russia
- Prior art keywords
- alkyl
- substituted
- hydrogen
- compound
- fluorine atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2012/043687 WO2013191704A1 (en) | 2012-06-22 | 2012-06-22 | Novel cabergoline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2014153672A true RU2014153672A (ru) | 2016-08-10 |
Family
ID=49769156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014153672A RU2014153672A (ru) | 2012-06-22 | 2012-06-22 | Новые каберголиновые производные |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP2863747A4 (zh) |
| JP (1) | JP2015525239A (zh) |
| CN (1) | CN104822264A (zh) |
| AU (1) | AU2012382929A1 (zh) |
| BR (1) | BR112014031945A2 (zh) |
| CA (1) | CA2876321A1 (zh) |
| HK (1) | HK1208997A1 (zh) |
| IL (1) | IL236310A0 (zh) |
| RU (1) | RU2014153672A (zh) |
| SG (1) | SG11201408567PA (zh) |
| WO (1) | WO2013191704A1 (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107428745A (zh) * | 2015-01-20 | 2017-12-01 | Xoc制药股份有限公司 | 麦角灵化合物及其用途 |
| CN106866656A (zh) * | 2017-02-28 | 2017-06-20 | 西南交通大学 | 一类麦角碱衍生物及其在预防和治疗精神疾病的用途 |
| EP3530651A1 (en) * | 2018-02-21 | 2019-08-28 | Adamed sp. z o.o. | Indole and benzimidazole derivatives as dual 5-ht2a and 5-ht6 receptor antagonists |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4526892A (en) * | 1981-03-03 | 1985-07-02 | Farmitalia Carlo Erba, S.P.A. | Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas |
| DK338789A (da) * | 1988-07-15 | 1990-01-16 | Schering Ag | 2-substituerede ergolinylurinstofderivater og fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler samt mellemprodukter til fremstilling deraf |
| DE3913756A1 (de) * | 1989-04-21 | 1990-10-25 | Schering Ag | 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung |
| WO1995005176A1 (en) * | 1993-08-18 | 1995-02-23 | Alcon Laboratories, Inc. | Use of ergoline derivatives for the treatment of glaucoma |
| CZ287176B6 (cs) * | 1997-10-03 | 2000-10-11 | Galena A. S. | Způsob přípravy ergolinových derivátů |
| EP1592424A1 (en) * | 2003-02-05 | 2005-11-09 | Pharmacia Italia S.p.A. | Cabergoline for the prophylactic treatment of migraine |
| GB0307377D0 (en) * | 2003-03-31 | 2003-05-07 | Merad Pharmaceuticals Ltd | Ergoline derivatives |
| HUP0400517A3 (en) * | 2004-03-04 | 2006-05-29 | Richter Gedeon Vegyeszet | Process for producing cabergoline |
| WO2006097345A1 (en) * | 2005-03-17 | 2006-09-21 | Synthon Argentina S.A. | Improved process for making cabergoline |
| GB0511060D0 (en) * | 2005-05-31 | 2005-07-06 | Novartis Ag | Organic compounds |
| EP2083008A1 (en) * | 2007-12-07 | 2009-07-29 | Axxonis Pharma AG | Ergoline derivatives as selective radical scavengers for neurons |
| WO2010081036A2 (en) * | 2009-01-09 | 2010-07-15 | President And Fellows Of Harvard College | Fluorine containing compounds and methods of use thereof |
| AU2010237100A1 (en) * | 2009-04-15 | 2011-10-27 | Astrazeneca Ab | Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as Alzheimer's disease |
| CA2859175A1 (en) * | 2011-12-21 | 2013-06-27 | Map Pharmaceuticals, Inc. | Novel neuromodulatory compounds |
-
2012
- 2012-06-22 CA CA2876321A patent/CA2876321A1/en not_active Abandoned
- 2012-06-22 JP JP2015518385A patent/JP2015525239A/ja active Pending
- 2012-06-22 WO PCT/US2012/043687 patent/WO2013191704A1/en active Application Filing
- 2012-06-22 CN CN201280075321.7A patent/CN104822264A/zh active Pending
- 2012-06-22 AU AU2012382929A patent/AU2012382929A1/en not_active Abandoned
- 2012-06-22 EP EP12879191.0A patent/EP2863747A4/en not_active Withdrawn
- 2012-06-22 BR BR112014031945A patent/BR112014031945A2/pt not_active IP Right Cessation
- 2012-06-22 RU RU2014153672A patent/RU2014153672A/ru unknown
- 2012-06-22 SG SG11201408567PA patent/SG11201408567PA/en unknown
-
2014
- 2014-12-17 IL IL236310A patent/IL236310A0/en unknown
-
2015
- 2015-10-12 HK HK15109927.2A patent/HK1208997A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2863747A4 (en) | 2015-12-23 |
| BR112014031945A2 (pt) | 2017-06-27 |
| WO2013191704A1 (en) | 2013-12-27 |
| AU2012382929A1 (en) | 2015-02-05 |
| JP2015525239A (ja) | 2015-09-03 |
| IL236310A0 (en) | 2015-02-26 |
| HK1208997A1 (zh) | 2016-03-24 |
| EP2863747A1 (en) | 2015-04-29 |
| CA2876321A1 (en) | 2013-12-27 |
| CN104822264A (zh) | 2015-08-05 |
| SG11201408567PA (en) | 2015-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2013158449A (ru) | Новые фторэрголиновые аналоги | |
| CY1118572T1 (el) | Παραγωγο κυκλοαλκανιου | |
| PH12016501204A1 (en) | Syk inhibitors | |
| EA201690094A1 (ru) | Ингибиторы syk | |
| RU2014140735A (ru) | ПРОИЗВОДНЫЕ ПИРАЗОЛО[1, 5-a]ПИРИМИДИНА, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ СОЕДИНЕНИЯ, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| EA201390766A1 (ru) | БЕНЗОКСАЗЕПИНЫ КАК ИНГИБИТОРЫ PI3K/mTOR И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ И ПОЛУЧЕНИЯ | |
| RU2013108348A (ru) | Конденсированные гетероарилы и их применение | |
| RU2015125591A (ru) | БЕНЗИЛСУЛЬФОНАМИДНЫЕ ПРОИЗВОДНЫЕ КАК МОДУЛЯТОРЫ RORc | |
| EA201690019A1 (ru) | Производное аминотриазина и содержащая его фармацевтическая композиция | |
| RU2015107803A (ru) | Производные дигидроксипиримидинкарбоновой кислоты и их применение в лечении, облегчении или предотвращении вирусного заболевания | |
| RU2013128448A (ru) | Производные триазола в качестве ингибиторов сигнального пути wnt | |
| EA201000557A1 (ru) | Производные тетрагидрохинолина для лечения посттравматических стрессовых расстройств | |
| EA201301209A1 (ru) | Производные пирролотриазинона в качестве ингибиторов p13k | |
| JP2015501820A5 (zh) | ||
| JP2014511892A5 (zh) | ||
| EA201370184A1 (ru) | Гетероарильные производные | |
| RU2014115796A (ru) | Модуляторы ror-гамма | |
| RU2017104856A (ru) | Функционализированные и замещенные индолы в качестве противораковых средств | |
| RU2012112050A (ru) | Производные дигидроптеридинона, способ их получения и фармацевтическое применение | |
| EA201600337A1 (ru) | 2,6-замещенные пуриновые производные и их применение в лечении пролиферативных заболеваний | |
| EA201391558A1 (ru) | Тетрагидропиразоло[1,5-а]пиримидины как противотуберкулезные соединения | |
| RU2013136895A (ru) | Новое бициклическое соединение или его соль | |
| RU2016101958A (ru) | Пиразольные соединения в качестве модуляторов fshr и их применение | |
| RU2019141734A (ru) | Терапевтические соединения и композиции и способы их применения | |
| RU2015150120A (ru) | Соединение дикарбоновой кислоты |